Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(17%)

Results Posted

25%(1 trials)

Phase Distribution

Ph not_applicable

17%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

2(66.7%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Terminated(1)

Detailed Status

Completed4

Recruiting1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 12 (66.7%)

N/A1 (33.3%)

Trials by Status

recruiting117%

withdrawn117%

completed467%

Recent Activity

1 active trials

Showing 5 of 6

recruiting

Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Response

NCT02480283

completednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT02480283

Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Response

Recruiting

NCT04089332Not Applicable

Insulin Resistance in Adolescents

Completed

NCT01810458

Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)

Completed

NCT02936687Phase 1

Mechanisms of Cerebrovascular Control

Completed

NCT03066115Phase 1

Impact of NOS, COX, and ROS Inhibition on Cerebral Blood Flow Regulation

Withdrawn

NCT01099410

Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)

Completed

All 6 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 6